decisionhealth Newsletters, Part B News - 2005 Issue 2 (February)
CMS has AMA recommendations on drug administration clarifications
Subscribe or sign in to view the full article.
Article Overview
This article covers proposed CMS clarifications affecting drug administration billing, with input from the AMA and discussion involving ASCO. It is aimed at coding and billing professionals who need to follow updates to HCPCS and CPT drug administration guidance, especially where CMS has not yet finalized changes. The article also touches on a chemotherapy demonstration project and broader questions about how certain administration scenarios may be handled.
Why This Topic Matters
Pending CMS guidance can affect how drug administration services are reported and reimbursed, so this update helps readers track areas of uncertainty before final instructions are issued.
What You Will Learn
- What kinds of drug administration billing questions were under review
- Which organizations were involved in discussing possible clarifications
- How pending CMS guidance could affect chemotherapy-related billing topics
- Why updates to drug administration instructions matter to coders and billers
Who Should Read This
- Medical coders
- Billing staff
- Oncology practice managers
- Compliance professionals
- Healthcare revenue cycle teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com